The UK's top immunology conference returns from Sunday 28 November to Wednesday 1 December – bigger and better than before! Based in the beautiful city of Edinburgh, our extensive programme boasts a diverse selection of immunology topics covering cutting-edge research from leading scientists around the world.
We also have a range of networking opportunities to allow you to exchange ideas and build links to aid your next career step. Explore the exciting sessions below and make sure you have a look through the full programme to plan your time at Congress.
For a guide to everything you need to know about BSI Congress 2021, including important COVID-19 information to read before arriving and tips to help you make the most of your Congress experience, read our blog here.
We look forward to welcoming many of you to Edinburgh!
Keynote session – in this prestigious session, Dr Rafi Ahmed will discuss ‘T cell lifestyle in chronic viral infections and cancer: Implications for immunotherapy’. This is a ‘must attend’ talk for all immunologists and promises the chance to hear Dr Ahmed discuss his groundbreaking research.
18:00–19:00, Sunday 28 November
Metabolic programming of immune responses – plenary session featuring Prof Andrew Mellor, Prof Edward Pearce and Dr Alice Prince
09:00–10:30, Monday 29 November
Human genetic determinants of infection and inflammation – plenary session featuring Dr Carl Anderson and Dr Jean-Laurent Casanova
16:30–17:30, Monday 29 November
Defining the state and functional relevance of T cell exhaustion – plenary session featuring Dr Andrea Schietinger, Dr Benjamin Youngblood and Prof Dietmar Zehn
09:00–10:30, Tuesday 30 November
Calling time on immunology – plenary session featuring Prof Andrew Loudon and Prof Christoph Scheiermann
16:30–17:30, Tuesday 30 November
Industry Satellite Symposia
Speaker: Dr Stephen Hague, Science & Technology Advisor, 10x Genomics
Speaker: Dr Bryan Serrels, Application Scientist nanoString: nanoString Spatial Biology
At the annual general meeting you can learn about the work of your Society, what activities we have carried out in the past year and what our plans are to support members and represent immunology in the UK. We encourage as many members as possible to attend.
17:30–18:00, Monday 29 November
We have a number of additional sessions running in which you can increase your knowledge on a range of topics that can boost your career and widen your horizons.
13:15–14:10, Monday 29 November
13:15–14:10, Tuesday 30 November
18:00–19:00, Tuesday 30 November
18:00–19:00, Tuesday 30 November
Throughout the conference, you can pop into the presentation theatre in the Exhibition Hall for 15-minute showcases presented by the BSI and our Corporate Sponsors on a variety of topics.
- BSI Immunology and COVID-19 Taskforce: how has the BSI represented the immunology community to policymakers during the pandemic?
- The BSI-NCRI Partnership: bringing together the immunology and cancer research communities
- Connect Immune Research: breaking down disease-specific research silos
- Securing our future, the importance of veterinary vaccines: BSI and IVVN collaboration for better animal and human health
- BSI Career Enhancing Grants: a scheme aimed at promoting career development and progression
- Communicating Immunology: how the BSI can support your public engagement activities
Presentations from our Corporate Sponsors
- FLUIDIGM: Simple and Affordable High-Throughput High-Dimensional Cytometry – INTRODUCING THE CYTOF XT
- TAKARA BIO EUROPE SAS: A complete solution for expressing and purifying vaccine targets with BakPAK Baculovirus Expression System and Capturem
- CURIOX BIOSYSTEMS: Next-Generation Cell Preparation with Laminar Wash™ technology
- BECKMAN COULTER LIFE SCIENCES: Cytobank platform: From data to insight – How analysis tools can support high complexity flow cytometry research
- STEMCELL TECHNOLOGIES: Tools for Immunology Research
Connect with us
The BSI is keen to keep you up to date with all the latest news from the BSI Congress. There are several ways you can connect with us.